Company Abliva AB Deutsche Boerse AG

Equities

NTP

SE0002575340

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

EPS Revisions

Annual profits - Rate of surprise

Sector Bio Therapeutic Drugs

Delayed Deutsche Boerse AG Other stock markets 08:46:25 17/07/2024 BST			5-day change	1st Jan Change
0.0128 ^EUR	+0.79%		+70.67%	+4.07%

05-30	Abliva Concludes Dosing in Mid-stage Study of Mitochondrial Disease Drug	MT
05-30	Abliva AB Announces Completion of 24 Weeks of Dosing in Wave 1 of the Falcon Study of KL1333 in Primary Mitochondrial Disease	CI

Abliva AB is a Sweden-based company involved in pharmaceutical industry. The Company focuses on the development of novel treatments for primary mitochondrial diseases.

Number of employees: 6

SEK in Million	2022	Weight	2023	Weight	Delta
Mitochondrial Diseases 100.0 %	0	100.0 %	0	100.0 %	+341.94%

SEK in Million	2022	Weight	2023	Weight	Delta
Sweden 100.0 %	0	100.0 %	0	100.0 %	+341.94%

Managers	Title	Age	Since
Ellen Donnelly CEO	Chief Executive Officer	50	02/02/21
Eskil Elmér FOU	Founder	54	31/01/00
Catharina Jz Johansson DFI	Director of Finance/CFO	57	30/11/13
Dag Nesse CTO	Chief Tech/Sci/R&D Officer	58	31/01/23
Magnus Hansson CTO	Chief Tech/Sci/R&D Officer	48	31/12/07

Members of the board	Title	Age	Since
David Laskow-Pooley CHM	Chairman	70	27/04/16
David Bejker BRD	Director/Board Member	49	26/04/17
Eskil Elmér FOU	Founder	54	31/01/00
Roger Franklin BRD	Director/Board Member	45	19/05/20
Denise Goode BRD	Director/Board Member	66	26/04/18
Jan Birger Fredrik Toernell BRD	Director/Board Member	64	26/04/17

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,056,299,165	930,212,762 ( 88.06 %)	0	88.06 %

Name	Equities	%	Valuation
FCG Fonder AB 0.1986 %	2,679,782	0.1986 %	33 846 €
Storebrand Asset Management AS 0.0601 %	811,308	0.0601 %	10 247 €
Skandia Fonder AB 0.0182 %	245,361	0.0182 %	3 099 €

Abliva AB

Medicon Village Scheeletorget 1

223 81, Lund

+46 4 62 75 62 20

http://www.abliva.com

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+20.17%	126B
REGENERON PHARMACEUTICALS, INC.	+24.67%	118B
ARGENX SE	+23.61%	27.87B
BIONTECH SE	-17.74%	20.95B
GENMAB A/S	-15.73%	16.92B
BEIGENE, LTD.	-15.21%	16.18B
NEUROCRINE BIOSCIENCES, INC.	+11.91%	14.84B
WUXI APPTEC CO., LTD.	-47.10%	14.79B
SAREPTA THERAPEUTICS, INC.	+54.50%	14.08B

Bio Therapeutic Drugs